In an elderly patient with Alzheimer disease taking donepezil, should the medication be continued on the day of surgery and what anesthesia precautions are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Donepezil and Anesthesia Management

Continue donepezil on the day of surgery, but be prepared for significant anesthetic complications requiring increased doses of neuromuscular blocking agents and potential resistance to non-depolarizing muscle relaxants. 1

Key Anesthetic Precautions

Neuromuscular Blockade Interactions

The FDA label explicitly warns that donepezil, as a cholinesterase inhibitor, is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia 1. However, clinical reality is more complex—multiple case reports demonstrate the opposite effect with non-depolarizing agents.

Paradoxical resistance to non-depolarizing muscle relaxants (rocuronium, atracurium, cisatracurium) has been documented in patients taking donepezil 2, 3, 4. This manifests as:

  • Unusually slow onset of neuromuscular blockade (up to 7 minutes for adequate intubating conditions versus typical 2-3 minutes) 3
  • Rapid recovery from blockade (TOF count returning within 1-2 minutes post-intubation) 3
  • Requirement for significantly higher doses than age-adjusted recommendations 4
  • Inadequate surgical relaxation despite repeated boluses 3, 4

Mechanism: Donepezil increases acetylcholine at the neuromuscular junction by inhibiting acetylcholinesterase, creating competitive antagonism against non-depolarizing agents that block acetylcholine receptors 3, 4.

Cardiovascular Monitoring

Cholinesterase inhibitors may produce vagotonic effects on cardiac conduction, manifesting as bradycardia or heart block in patients with or without underlying cardiac abnormalities 1. Syncopal episodes have been reported with donepezil use 1.

  • Maintain continuous ECG monitoring
  • Have atropine or glycopyrrolate immediately available
  • Consider avoiding additional vagotonic agents when possible

Practical Anesthetic Management Algorithm

1. Preoperative Assessment:

  • Document donepezil dose and duration of therapy
  • Obtain baseline ECG (look for conduction abnormalities)
  • Inform surgical team of potential for inadequate muscle relaxation

2. Induction Strategy:

  • Use train-of-four (TOF) monitoring from the start 3
  • Anticipate 2-3x normal induction dose of non-depolarizing agents 4
  • Allow extended time (up to 7 minutes) before intubation attempt 3
  • Have alternative airway management plan ready

3. Maintenance Considerations:

  • Continuous TOF monitoring throughout case 3
  • Consider switching to inhalational anesthetics if inadequate relaxation persists with TIVA 3
  • May require continuous infusion of muscle relaxant rather than bolus dosing 3
  • Alternative: cisatracurium may provide better blockade than rocuronium in this population 3

4. Emergence Planning:

  • Paradoxically, despite resistance during maintenance, delayed neuromuscular recovery can occur postoperatively due to cumulative effects of high-dose relaxants 4
  • Ensure adequate reversal with neostigmine/sugammadex
  • Have ventilatory support available in recovery area 4

Medication Continuation Rationale

Do not discontinue donepezil perioperatively unless absolutely necessary. The 2015 American Geriatrics Society guideline strongly recommends against newly prescribing cholinesterase inhibitors perioperatively to prevent delirium 5, but this does not apply to patients already taking these medications chronically.

Rationale for continuation:

  • Abrupt discontinuation risks cognitive deterioration and withdrawal effects
  • No evidence that continuation increases delirium risk in established users 5
  • The modest cognitive benefits (5-15% improvement over placebo) 6 are maintained with continuous therapy
  • Elderly patients with dementia undergoing surgery are already at high risk for postoperative cognitive dysfunction 7

The 2014 AAGBI guideline on perioperative care of the elderly emphasizes maintaining established medications for chronic conditions unless specific contraindications exist 8. Recent expert consensus on perioperative brain health supports continuing cognitive-enhancing medications in patients with established dementia 7.

Common Pitfalls to Avoid

  1. Assuming standard muscle relaxant dosing will suffice - This is the most dangerous error. Always use TOF monitoring and be prepared to significantly increase doses 2, 3, 4.

  2. Stopping donepezil "to be safe" - This creates more harm than benefit through cognitive deterioration without eliminating anesthetic interactions (drug effects persist for days due to long half-life).

  3. Failing to communicate with the surgical team - Inadequate muscle relaxation can compromise surgical conditions, particularly for laparoscopic procedures 3.

  4. Inadequate postoperative monitoring - The combination of high-dose relaxants and cholinesterase inhibition creates risk for delayed recovery requiring extended ventilatory support 4.

  5. Using succinylcholine without preparation - While the FDA warns of exaggerated response to depolarizing agents 1, have immediate airway management capability as the interaction may be unpredictable.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.